Physicians caring for persons with type 1 diabetes might be better able to assess the role of oxidative stress in determining their patient’s chances of developing heart disease if they also consider the levels of protective antioxidants in the patient’s blood, according to a new study from the University of Pittsburgh Graduate School of Public Health. The study, funded by the National Institutes of Health (NIH), was recently published in the journal Diabetes Care. It relied on data from the “Pittsburgh Epidemiology of Diabetes Complications,” a historical prospective investigation of childhood onset type 1 diabetes cases diagnosed, or seen within one year of diagnosis, at Children’s Hospital of Pittsburgh between 1950 and 1980.